Abstract:Background: Inhibition of human carcinomas has previously been linked to vitamin D due to its effects on cancer cell proliferation, migration, angiogenesis, and apoptosis induction. The anticancer activity of vitamin D has been confirmed by several studies, which have shown that increased cancer incidence is associated with decreased vitamin D and that dietary supplementation of vitamin D slows down the growth of xenografted tumors in mice. Vitamin D inhibits the growth of cancer cells by the induction of apoptosis as well as by arresting the cells at the G0/G1 (or) G2/M phase of the cell cycle. Aim and Key Scientific Concepts of the Review: The purpose of this article is to thoroughly review the existing information and discuss and debate to conclude whether vitamin D could be used as an agent to prevent/treat cancers. The existing empirical data have demonstrated that vitamin D can also work in the absence of vitamin D receptors (VDRs), indicating the presence of multiple mechanisms of action for this sunshine vitamin. Polymorphism in the VDR is known to play a key role in tumor cell metastasis and drug resistance. Although there is evidence that vitamin D has both therapeutic and cancer-preventive properties, numerous uncertainties and concerns regarding its use in cancer treatment still exist. These include (a) increased calcium levels in individuals receiving therapeutic doses of vitamin D to suppress the growth of cancer cells; (b) hyperglycemia induction in certain vitamin D-treated study participants; (c) a dearth of evidence showing preventive or therapeutic benefits of cancer in clinical trials; (d) very weak support from proof-of-principle studies; and (e) the inability of vitamin D alone to treat advanced cancers. Addressing these concerns, more potent and less toxic vitamin D analogs have been created, and these are presently undergoing clinical trial evaluation. To provide key information regarding the functions of vitamin D and VDRs, this review provided details of significant advancements in the functional analysis of vitamin D and its analogs and VDR polymorphisms associated with cancers.

Delineating the Immunotherapeutic Potential of Vitamin E and Its Analogues in Cancer: A Comprehensive Narrative Review

Vitamin E and its anticancer effects

Vitamin E-based nanomedicines for anti-cancer drug delivery

Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis.

Advances in Vitamin E and its Potential Role in Cancer Therapy

Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery

Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies

The potential role of vitamin C in empowering cancer immunotherapy

Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1

Vitamin E Transporters in Cancer Therapy

Data from Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells Via Targeting Checkpoint SHP1

Repurposing Vitamin C for Cancer Treatment: Focus on Targeting the Tumor Microenvironment

Tocotrienol isoforms: The molecular mechanisms underlying their effects in cancer therapy and their implementation in clinical trials

Immunotherapy: A New Target for Cancer Cure (Review)

Vitamin E and Non-Communicable Diseases: A Review

The rise, the fall and the renaissance of vitamin E

Vitamin C As an Anticancer Agent: Regulation of Signaling Pathways

The impact of vitamin D on cancer: A mini review

Vitamin D and potential effects on cancers: a review

The immunomodulatory effects of vitamins in cancer

Vitamin K and Its Analogs: Potential Avenues for Prostate Cancer Management